Pituitary Cancer Market, By Cancer Type (Pituitary Adenoma (Benign Tumor), Pituitary Carcinoma (Malignant Tumor)), By Hormone Type (Prolactinoma, Growth Hormone-Secreting Tumor (Acromegaly), Adrenocorticotropic Hormone-Secreting Tumor (Cushing\'s Disease)

Pituitary Cancer Market, By Cancer Type (Pituitary Adenoma (Benign Tumor), Pituitary Carcinoma (Malignant Tumor)), By Hormone Type (Prolactinoma, Growth Hormone-Secreting Tumor (Acromegaly), Adrenocorticotropic Hormone-Secreting Tumor (Cushing\'s Disease), Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma), Gonadotropin-Secreting Tumor), By Treatment Type (Surgery, Radiation Therapy, Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy), Targeted Therapy, Chemotherapy), By Age Group (Pediatric, Adult), By End User (Hospitals, Specialty Clinics, Cancer Treatment Centers, Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pituitary cancer market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market
Global Pituitary Cancer Market Detailed Segmentation:
  • By Cancer Type:
  • Pituitary Adenoma (Benign Tumor)
  • Pituitary Carcinoma (Malignant Tumor)
  • By Hormone Type:
  • Prolactinoma
  • Growth Hormone-Secreting Tumor (Acromegaly)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
  • Gonadotropin-Secreting Tumor
  • By Treatment Type:
  • Surgery
  • Radiation Therapy
  • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
  • Targeted Therapy
  • Chemotherapy
  • By Age Group:
  • Pediatric
  • Adult
  • By End User:
  • Hospitals
  • Specialty Clinics
  • Cancer Treatment Centers
  • Research Institutes
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • Company Profile:
  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc.
  • Debiopharm International SA


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Pituitary Cancer, By Cancer Type
Market Pituitary Cancer, By Hormone Type
Market Pituitary Cancer, By Treatment Type
Market Pituitary Cancer, By Age Group
Market Pituitary Cancer, By End User
Market Pituitary Cancer, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing Incidence and Prevalence
Advancements in Medical Imaging and Diagnostics
Increased Research and Development
Growing Demand for Personalized Medicine
Restraints
Limited Awareness and Delayed Diagnosis
Lack of Standardized Treatment Guidelines
Limited Treatment Options for Aggressive Pituitary Cancers
Challenges in Drug Development
Opportunities
Development of Targeted Therapies
Combination Therapies
Advancements in Surgical Techniques
Development of Novel Imaging Modalities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Pituitary Cancer Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Pituitary Cancer Market , By Cancer Type, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Pituitary Adenoma (Benign Tumor)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Pituitary Carcinoma (Malignant Tumor)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
6. Pituitary Cancer Market , By Hormone Type, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Prolactinoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Growth Hormone-Secreting Tumor (Acromegaly)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Gonadotropin-Secreting Tumor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
7. Pituitary Cancer Market , By Treatment Type, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Surgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Radiation Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Targeted Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
8. Pituitary Cancer Market , By Age Group, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
9. Pituitary Cancer Market , By End User, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Cancer Treatment Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
10. Pituitary Cancer Market , By Region, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018–2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
GCC
Israel
North Africa
Central Africa
Rest of Middle East & Africa
11. Competitive Landscape
Novartis International AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Ipsen Biopharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Endocyte
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
RECORDATI GROUP
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Camurus AB
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Endeavor Biomedicines, Inc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Debiopharm International SA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
12. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Pituitary Cancer Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings